Frequency of Carcinoma Prostate in Patients Undergoing Transurethral Resection of Prostate for Clinically Benign Prostatic Hyperplasia
DOI:
https://doi.org/10.54112/bcsrj.v6i11.2104Keywords:
Incidental prostate cancer; benign prostatic hyperplasia; transurethral resection of prostate; histopathologyAbstract
Incidental carcinoma prostate refers to prostate cancer detected unexpectedly on histopathological examination of tissue resected for clinically benign prostatic hyperplasia. Despite advances in prostate-specific antigen screening, incidental carcinoma remains clinically relevant, particularly in aging populations. Data from Pakistan on this entity are limited, necessitating local evidence to guide clinical practice. Objective: To determine the frequency of incidental prostate carcinoma in patients undergoing transurethral resection of the prostate for clinically benign prostatic hyperplasia and to evaluate associated demographic and clinical factors. Methods: This descriptive cross-sectional study was conducted at the Department of Urology, Kidney Centre, Bahawal Victoria Hospital, Bahawalpur, from May to August 2025. A total of 124 male patients aged 50–80 years with clinically benign prostatic hyperplasia undergoing transurethral resection of the prostate were enrolled through non-probability consecutive sampling. Patients with prior prostate surgery, known prostate cancer, or lower urinary tract infection were excluded. Clinical data, including age, duration of symptoms, prostate size, serum prostate-specific antigen levels, smoking status, family history of prostate cancer, history of prostatitis, and obesity, were recorded. Resected specimens were examined histopathologically for prostate carcinoma. Data were analysed using SPSS version 25.0, and associations were assessed using chi-square or Fisher’s exact test, with p ≤ 0.05 considered statistically significant. Results: The mean age of patients was 64.2 ± 7.8 years. Incidental prostate carcinoma was detected in 13 patients, yielding a frequency of 10.5%. The detection rate increased significantly with advancing age, particularly in patients aged 71–80 years (p = 0.041). Carcinoma prostate was significantly associated with longer duration of symptoms (>12 months), larger prostate size (>60 g), higher serum prostate-specific antigen levels (≥3 ng/ml), and positive family history of prostate cancer. Smoking status, obesity, and history of prostatitis showed no statistically significant association. Conclusion: Incidental carcinoma of the prostate is not uncommon among Pakistani patients undergoing transurethral resection of the prostate for clinically benign prostatic hyperplasia. Advancing age, increased prostate volume, prolonged symptom duration, elevated prostate-specific antigen levels within the normal range, and family history are significant predictors. Routine histopathological evaluation of all transurethral resection specimens remains essential for early detection and optimal patient management.
Downloads
References
Shah R. and Pandey D. Relation of age and serum prostatic-specific antigen level with histopathological Diagnosis in transurethral resection of prostate specimen, an experience from eastern tertiary hospital. Journal of Nepalgunj Medical College 2019;17(2):62-65. https://doi.org/10.3126/jngmc.v17i2.31657
Abedi A., Razzaghi M., Rahavian A., Hazrati E., Aliakbari F., Vahedisoraki V.et al.. Is holmium laser enucleation of the prostate a good surgical alternative in benign prostatic hyperplasia management? A review article. Journal of Lasers in Medical Sciences 2020;11(2):197-203. https://doi.org/10.34172/jlms.2020.33
Tominaga Y., Sadahira T., Mitsui Y., Maruyama Y., Tanimoto R., Wada K., et al. Favourable long-term oncological and urinary outcomes of incidental prostate cancer following holmium laser enucleation of the prostate. Molecular and Clinical Oncology 2019. https://doi.org/10.3892/mco.2019.1839
Raphael J. and Ekeke O. T1a/t1b transitional zone prostate cancer detection rates in patients who had turp for clinically diagnosed benign prostatic enlargement in southern Nigeria. European Journal of Health Sciences 2022;7(2):1-7. https://doi.org/10.47672/ejhs.995
Zulfikar M., Rizaldi F., Kloping Y., Rahman Z., & Djatisoesanto W. Erectile function of BPH patients undergoing a laser procedure compared to a standard transurethral resection of the prostate (TURP): a systematic review and meta-analysis. International Journal of Research Publications 2022;93(1). https://doi.org/10.47119/ijrp100931120222793
Prostate cancer after surgery for benign prostate hyperplasia. 2022. https://doi.org/10.20903/zpopov-2022-0006
Mohamed A., Abdullahi I., Warsame F., & Mohamud H. Incidence and associated factors for incidental prostate cancer among patients who underwent surgery for benign prostatic hyperplasia: first report from Somalia. Journal of Cancer Research and Clinical Oncology 2022;149(7):4041-4046. https://doi.org/10.1007/s00432-022-04319-0
Haque M., Latif M., Siddique M., Nizami N., Nandy S., & Ghose A. Incidental Diagnosis of carcinoma prostate of turp chips done for BPH: a study of Chittagong Medical College Hospital. Journal of Chittagong Medical College Teachers Association 2018;28(2):16-20. https://doi.org/10.3329/jcmcta.v28i2.62404
Rosenbaum C., Vetterlein M., Fisch M., Reiss P., Worst T., Kranz J., et al Contemporary outcomes after transurethral procedures for bladder neck contracture following endoscopic treatment of benign prostatic hyperplasia. Journal of Clinical Medicine 2021;10(13):2884. https://doi.org/10.3390/jcm10132884
Kızılkan Y., Eroğlu Ü., Şenel S., Yıldızhan M., Balcı M., Aykanat İ.et al.. Evaluation of factors associated with the detection of incidental prostate cancer after open prostatectomy for benign prostatic hyperplasia. Andrologia 2021;54(1). https://doi.org/10.1111/and.14261
Nomani B., Alamgir M., Qayyum M., Raza S., Faisal H., & Nadeem S. Frequency of various histopathological types of prostatic diseases in a tertiary care hospital at Karachi. The Professional Medical Journal 2022;29(08):1147-1151. https://doi.org/10.29309/tpmj/2022.29.08.6840
Raphael J. and Ekeke O. T1a/t1b transitional zone prostate cancer detection rates in patients who had turp for clinically diagnosed benign prostatic enlargement in southern Nigeria. European Journal of Health Sciences 2022;7(2):1-7. https://doi.org/10.47672/ejhs.995
Kızılkan Y., Eroğlu Ü., Şenel S., Yıldızhan M., Balcı M., Aykanat İ.et al.. Evaluation of factors associated with the detection of incidental prostate cancer after open prostatectomy for benign prostatic hyperplasia. Andrologia 2021;54(1). https://doi.org/10.1111/and.14261
Mohamed A., Abdullahi I., Warsame F., & Mohamud H. Incidence and associated factors for incidental prostate cancer among patients who underwent surgery for benign prostatic hyperplasia: first report from Somalia. Journal of Cancer Research and Clinical Oncology 2022;149(7):4041-4046. https://doi.org/10.1007/s00432-022-04319-0
Kızılkan Y., Şenel S., Balcı M., Yıldızhan M., Aykanat İ., Eroğlu Ü.et al.. Evaluation of factors associated with the detection of incidental prostate cancer after open prostatectomy for benign prostatic hyperplasia. 2024. https://doi.org/10.22541/au.170666094.47076314/v1
Haque M., Latif M., Siddique M., Nizami N., Nandy S., & Ghose A. Incidental Diagnosis of carcinoma prostate of turp chips done for BPH: a study of Chittagong Medical College Hospital. Journal of Chittagong Medical College Teachers Association 2018;28(2):16-20. https://doi.org/10.3329/jcmcta.v28i2.62404
Capogrosso P., Capitanio U., Vertosick E., Ventimiglia E., Chierigo F., Oreggia D.et al. Temporal trend in incidental prostate cancer detection at surgery for benign prostatic hyperplasia. Urology 2018;122:152-157. https://doi.org/10.1016/j.urology.2018.07.028
Guo Z., He J., Huang L., Wang Z., Hu P., Wang S.et al.. Prevalence and risk factors of incidental prostate cancer in certain surgeries for benign prostatic hyperplasia: a systematic review and meta-analysis. International Braz J Urol 2022;48(6):915-929. https://doi.org/10.1590/s1677-5538.ibju.2021.0653
Neha K., Zakaria F., Khan A., Urahiman M., & D'Souza N. Incidental detection of prostate cancer in transurethral resection of prostate (TURP) specimens: a retrospective study. PIJR 2023:40-42. https://doi.org/10.36106/paripex/3604425
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Muhammad Arslan Javed, Mumtaz Rasool, Mian Adnan Aslam Javaid

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

